ARCHIVES

Arimidex Continues To Show Improvement Over Tamoxifen

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

ACCC Unit Reaches Consensus On Outline of HOP; Each Member Would Relate To Center Or Cooperative Group

September 11, 1981

DCT Program Cutbacks Planned as Research Stressed In 4 Cancers

February 26, 1993

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

Cooperative Groups Not Included Among Grants to Be Funded At Recommended Levels

November 11, 1983